Articles:

DJ Snyders and A Chaudhary

High affinity open channel block by dofetilide of HERG expressed in a human cell line
Mol Pharmacol 1996 49: 949-955. [Abstract] [PDF]  

CJ Van Koppen, D Meyer Zu Heringdorf, C Zhang, KT Laser, and KH Jakobs

A distinct G(i) protein-coupled receptor for sphingosylphosphorylcholine in human leukemia HL-60 cells and human neutrophils
Mol Pharmacol 1996 49: 956-961. [Abstract] [PDF]  

BD Stride, G Valdimarsson, JH Gerlach, GM Wilson, SP Cole, and RG Deeley

Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter
Mol Pharmacol 1996 49: 962-971. [Abstract] [PDF]  

R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid, and CE Myers

Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene
Mol Pharmacol 1996 49: 972-979. [Abstract] [PDF]  

IJ Lee, KS Jeong, BJ Roberts, AT Kallarakal, P Fernandez-Salguero, FJ Gonzalez, and BJ Song

Transcriptional induction of the cytochrome P4501A1 gene by a thiazolium compound, YH439
Mol Pharmacol 1996 49: 980-988. [Abstract] [PDF]  

PC Liu, MA Phillips, and F Matsumura

Alteration by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of CCAAT/enhancer binding protein correlates with suppression of adipocyte differentiation in 3T3-L1 cells
Mol Pharmacol 1996 49: 989-997. [Abstract] [PDF]  

RR Cobb, KA Felts, GC Parry, and N Mackman

D609, a phosphatidylcholine-specific phospholipase C inhibitor, blocks interleukin-1 beta-induced vascular cell adhesion molecule 1 gene expression in human endothelial cells
Mol Pharmacol 1996 49: 998-1004. [Abstract] [PDF]  

P Kramata, I Votruba, B Otova, and A Holy

Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogs toward DNA polymerases alpha, delta and epsilon
Mol Pharmacol 1996 49: 1005-1011. [Abstract] [PDF]  

F Ali-Osman, G Antoun, H Wang, S Rajagopal, and E Gagucas

Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells
Mol Pharmacol 1996 49: 1012-1020. [Abstract] [PDF]  

GH Hockerman, ME Girvin, CC Malbon, and AE Ruoho

Antagonist conformations with the beta(2)-adrenergic receptor ligand binding pocket
Mol Pharmacol 1996 49: 1021-1032. [Abstract] [PDF]  

RT Jr Fremeau, M Velaz-Faircloth, JW Miller, VA Henzi, SM Cohen, JV Nadler, S Shafqat, RD Blakely, and B Domin

A novel nonopioid action of enkephalins: competitive inhibition of the mammalian brain high affinity L-proline transporter
Mol Pharmacol 1996 49: 1033-1041. [Abstract] [PDF]  

WC Glasgow, EM Hill, SR McGown, KB Tomer, and TE Eling

Regulation of 13(S)-hydroxyoctadecadienoic acid biosynthesis in Syrian hamster embryo fibroblasts by the epidermal growth factor receptor tyrosine kinase
Mol Pharmacol 1996 49: 1042-1048. [Abstract] [PDF]  

SW Bahouth, Y Gokmen-Polar, EC Coronel, and JN Fain

Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate
Mol Pharmacol 1996 49: 1049-1057. [Abstract] [PDF]  

F Rodriguez-Pascual, MT Miras-Portugal, and M Torres

Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase
Mol Pharmacol 1996 49: 1058-1070. [Abstract] [PDF]  

MA Forget, N Lebel, P Sirois, Y Boulanger, and A Fournier

Biological and molecular analyses of structurally reduced analogues of endothelin-1
Mol Pharmacol 1996 49: 1071-1079. [Abstract] [PDF]  

A Buhr, R Baur, P Malherbe, and E Sigel

Point mutations of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid(A) receptor affecting modulation of the channel by ligands of the benzodiazepine binding site
Mol Pharmacol 1996 49: 1080-1084. [Abstract] [PDF]  

S Kallia-Raftopoulos, D Synetos, HC Ottenheijm, LA van den Broek, and C Coutsogeorgopoulos

Sparsomycin and its analogues: a new approach for evaluating their potency as inhibitors of peptide bond formation
Mol Pharmacol 1996 49: 1085-1091. [Abstract] [PDF]  

L Laakkonen, W Li, JH Perlman, F Guarnieri, R Osman, KD Moeller, and MC Gershengorn

Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone
Mol Pharmacol 1996 49: 1092-1096. [Abstract] [PDF]  

DW Pyatt, WS Stillman, and RD Irons

Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells
Mol Pharmacol 1996 49: 1097-1103. [Abstract] [PDF]  

AK Ho, T Ogiwara, and CL Chik

Thapsigargin modulates agonist-stimulated cyclic AMP responses through cytosolic calcium-dependent and -independent mechanisms in rat pinealocytes
Mol Pharmacol 1996 49: 1104-1112. [Abstract] [PDF]  

X Ding, DC Spink, JK Bhama, JJ Sheng, AD Vaz, and MJ Coon

Metabolic activation of 2,6-dichlorobenzonitrile, an olfactory-specific toxicant, by rat, rabbit, and human cytochromes P450
Mol Pharmacol 1996 49: 1113-1121. [Abstract] [PDF]  

P Chiba, G Ecker, D Schmid, J Drach, B Tell, S Goldenberg, and V Gekeler

Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance
Mol Pharmacol 1996 49: 1122-1130. [Abstract] [PDF]  

K Kashiwagi, J Fukuchi, J Chao, K Igarashi, and K Williams

An aspartate residue in the extracellular loop of the N-methyl-D- aspartate receptor controls sensitivity to spermine and protons
Mol Pharmacol 1996 49: 1131-1141. [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.